Ibarani, Jenilyn .

HRN: 16-50-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CEFUROXIME 750MG (VIAL)
12/27/2025
12/28/2025
IV
750 Mg
Every 8 Hours
S/P NSVD With Inc Wbc
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines